Amifostine shortens bone marrow recovery period in breast cancer patients.
D004999:Amifostine / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects*; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000188:drug therapy / Q000628:therapy*; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007962:Leukocytes / Q000378:metabolism
D003520:Cyclophosphamide; D004999:Amifostine; C011272:perfosfamide